Jag Capital Management’s Boston Scientific BSX Stock Holding History

Jag Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,955	Closed	-$7.53M	–	152
2025 Q4	$7.53M	Sell	78,955 -75,797	-49%	-$7.43M	0.82%	33
2025 Q3	$15.1M	Sell	154,752 -3,714	-2%	-$385K	1.65%	21
2025 Q2	$17M	Sell	158,466 -57,769	-27%	-$5.85M	1.9%	18
2025 Q1	$21.8M	Buy	216,235 +45,983	+27%	+$4.63M	2.91%	8
2024 Q4	$15.2M	Sell	170,252 -131,254	-44%	-$11.6M	2.12%	16
2024 Q3	$25.3M	Buy	301,506 +27,720	+10%	+$2.19M	3.05%	7
2024 Q2	$21.1M	Buy	273,786 +62,480	+30%	+$4.57M	2.89%	10
2024 Q1	$14.5M	Buy	+211,306	New	+$13.6M	2.05%	16
2017 Q1	–	Sell	-53,000	Closed	-$1.15M	–	110
2016 Q4	$1.15M	Sell	53,000 -379,973	-88%	-$8.29M	0.23%	76
2016 Q3	$10.3M	Buy	+432,973	New	+$10.3M	2.02%	18

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jag Capital Management's BSX Position: Q1 2026 in Review

Jag Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 78,955 shares — an estimated $7.53M sold.

Jag Capital Management first reported a position in BSX in Q3 2016 and held it in 10 quarters. The position peaked at $25.3M in Q3 2024. 1,681 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Jag Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Jag Capital Management sold 78,955 Boston Scientific shares in Q1 2026, an estimated $7.53M.
Jag Capital Management first reported a position in Boston Scientific in Q3 2016 and held it in 10 quarters.
Jag Capital Management's Boston Scientific position peaked at $25.3M in Q3 2024.
1,681 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Jag Capital Management's 13F filing for Q1 2026, filed 6 May 2026.